GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (FRA:8LY) » Definitions » YoY Rev. per Sh. Growth

OncoZenge AB (FRA:8LY) YoY Rev. per Sh. Growth : 0.00% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is OncoZenge AB YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. OncoZenge AB's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 0.00%.

OncoZenge AB's Revenue per Share for the three months ended in Mar. 2025 was €0.02.

OncoZenge AB YoY Rev. per Sh. Growth Historical Data

The historical data trend for OncoZenge AB's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoZenge AB YoY Rev. per Sh. Growth Chart

OncoZenge AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
YoY Rev. per Sh. Growth
- - - - -

OncoZenge AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OncoZenge AB YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

OncoZenge AB's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2024 )
=(Revenue per Share (A: Dec. 2024 )-Revenue per Share (A: Dec. 2023 ))/ | Revenue per Share (A: Dec. 2023 ) |
=(0-0)/ | 0 |
=N/A %

OncoZenge AB's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=(Revenue per Share (Q: Mar. 2025 )-Revenue per Share (Q: Mar. 2024 )) / | Revenue per Share (Q: Mar. 2024 )) |
=(0.021-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoZenge AB YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of OncoZenge AB's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoZenge AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (FRA:8LY) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
OSTO:EXPRS2 OSTO:ATORX XSAT:NIDHOG XSAT:CHOSA OSTO:MODTX OSTO:ACOU OSTO:2CUREX OSTO:COMBI OSTO:CMOTEC B OSTO:BIOVIC B VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ONCOZ:Sweden
Address
Gustavslundsvagen 34, Bromma, SWE, 167 51
Website
https://www.oncozenge.com
OncoZenge AB is a pharmaceutical company that is developing a new treatment for effective pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. In phase 2 patient studies, the company's product candidate BupiZenge displayed pain relief compared with standard therapy. It focuses on implementing a phase development program as a basis for regulatory approvals and product launches.

OncoZenge AB Headlines

No Headlines